Skip to main content
. 2015 Nov 26;18(7):663–671. doi: 10.1111/jch.12727

Figure 1.

Figure 1

The process is shown for deriving the study sample of statin‐eligible nonhypertensive and hypertensive adults aged 21 to 80 years from the subset of 428,802 with sufficient clinical data to assess atherosclerotic cardiovascular disease risk. BP indicates blood pressure; ESRD, end‐stage renal disease; CHF, congestive heart failure; ATP‐3, Third Report of the Adult Treatment Panel III.